Chimeric Antibodies

Chimeric antibodies are antibodies made up of gene fragments from different species. Combined through a genetic engineering process, these gene fragments form a novel molecule with unique properties.

Chimeric antibodies were developed due to poor effectiveness of mouse antibodies in human therapeutics owing to the immune response triggered by the presence of foreign mouse proteins. Chimeric antibodies provide a solution to this problem by maintaining constant regions of a human antibody, linked to variable regions of mouse antibody. This combination of the two species’ antibody regions reduces immunogenicity whilst still allowing for high binding specificity.


This week, Biorbyt has put together a short guide to Chimeric Antibodies where we discuss the various applications of this growing research and therapeutic tool. 


 

 

Popular Chimeric Antibody Products

SARS-CoV-2 RBD Potent Neutralizing Antibody

Anti-IL2RA (basiliximab biosimilar) mAb

Anti-CD96 antibody, IgG1 Chimeric mAb

Explore the full Biorbyt catalog of chimeric antibodies



DBA-ITALIA Srl
Via Umbria 10
20054 Segrate (Milano)

info@dbaitalia.it